Zyceva-150 Erlotinib Tablets 150mg

Get a Price/Quote

MOQ : 10 Pieces

Zyceva-150 Erlotinib Tablets 150mg Specification

Indication
Non-small cell lung cancer, pancreatic cancer

Salt Composition
Erlotinib 150mg

Dosage Form
Tablet

Feature
Targeted cancer therapy, oral administration

Ingredients
Erlotinib Hydrochloride and excipients

Application
Oncology/Anticancer therapy

Physical Color/Texture
Tablet, likely white or off-white

Storage Instructions
Store in a cool, dry place below 30C, protect from light

Shelf Life
24 months from manufacturing

Strength
150 mg per tablet

Box Color
White and pink packaging with turquoise accent

Pack Size
30 tablets per box

Brand Name
Zyceva-150

Prescription Status
Prescription only medicine

Route of Administration
Oral

Market Availability
Available internationally (noted for Canada, EU, UK, US, Australia)

Zyceva-150 Erlotinib Tablets 150mg About

Experience the sensational efficacy of Zyceva-150 Erlotinib Tablets, available at the lowest price online. This masterpiece in targeted oncology therapy comes in a convenient 30-tablet box, each tablet delivering 150 mg of Erlotinib Hydrochloride. Designed for oral administration, Zyceva-150 is a stellar choice for managing non-small cell lung cancer and pancreatic cancer. Its favorable reviews highlight the simplicity of use and impactful results. Available internationally, in signature white and pink packaging with a turquoise accent, this prescription-only medicine stands out for both its therapeutic excellence and reliable supply from leading Indian manufacturers, suppliers, and traders.

Zyceva-150 Erlotinib Tablets: Oncological Application & Use Type

Zyceva-150 Erlotinib Tablets 150mg are primarily prescribed for oncology, specifically the management and treatment of non-small cell lung cancer and pancreatic cancer. These are intended for use in adult patients as per physician guidance. Zyceva-150 represents a plant-manufactured, prescription-only medication, formulated as oral tablets for ease of use in clinical and home settings. Its broad application across multiple cancer types reaffirms its status as a leading, trusted choice for cancer care professionals and patients alike.

Seamless Delivery & Export Market Presence for Zyceva-150

Logistics solutions ensure that Zyceva-150 Erlotinib Tablets 150mg are efficiently delivered to major markets such as Canada, the EU, UK, US, and Australia. All proposal amount details and purchase terms are communicated in advance, with a focus on transparency and reliability. The product is shipped from India-its main FOB port-to customers and distributors globally, making the delivery process streamlined and accessible for international buyers in need of trusted anticancer therapy.

FAQ's of Zyceva-150 Erlotinib Tablets 150mg:

Q: How should Zyceva-150 Erlotinib Tablets 150mg be administered?

A: Zyceva-150 should be taken orally, exactly as prescribed by a qualified healthcare provider. Follow the dosage instructions carefully to ensure optimal effectiveness.

Q: What conditions are Zyceva-150 Tablets indicated for?

A: Zyceva-150 is used in the treatment of non-small cell lung cancer and pancreatic cancer, forming part of targeted anticancer therapy regimens.

Q: When can patients expect delivery after purchase?

A: Delivery timelines vary based on destination, but logistics partners strive to ensure prompt and secure delivery internationally, including to the US, Canada, UK, EU, and Australia.

Q: Where is Zyceva-150 manufactured and exported from?

A: Zyceva-150 is manufactured in India and exported worldwide, with shipments primarily dispatched from the main FOB port in India.

Q: What are the benefits of using Zyceva-150 Erlotinib Tablets?

A: The key benefit is its targeted mechanism, providing effective therapy for certain cancers with convenient oral administration and reliable international availability.